The patient experienced severe back pain that he managed with steroids, leading to harmful side effects like weight gain and ...
Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the ...
Nevro recently added a minimally invasive treatment option for patients in the U.S. suffering from chronic sacroiliac joint ( ...
Nevro Corp. , a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today reported its third-quarter 2024 financial results, ...
GlobalData on MSN14h
Nevro secures CE mark for AI-based spinal cord stimulation systemUS-based device company Nevro has secured market authorisation from the European Union (EU) for its HFX iQ spinal cord ...
The sacroiliac joint is a common source of chronic lower back pain and a novel RFA-based approach to sacroiliac joint denervation may provide intermediate-term pain relief and functional benefit ...
A diagnostic delay of 2 to 6 years may be typical in axSpA, noted Raj Sengupta, MBBS, of the University of Bath in England, ...
U.S. Marine veteran and adaptive sports athlete Mike Ricci is helping others deal with physical and emotional issues after he ...
Its product, iFuse, seeks to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that often causes severe lower back pain. The company was founded by Mark A. Reiley and Jeffrey W. Dunn on ...
Q3 2024 Earnings Conference Call November 11, 2024 4:30 PM ETCompany ParticipantsAngie McCabe - Vice President, Investor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback